Diabetes Metab J.  2021 Jul;45(4):617-618. 10.4093/dmj.2021.0152.

Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)

• Kim KJ
• Choi J
• Bae JH
• Kim KJ
• Yoo HJ
• Seo JA
• Kim NH
• Choi KM
• Baik SH
• Kim SG
• Kim NH

• KMID: 2518905
• DOI: http://doi.org/10.4093/dmj.2021.0152

Reference

1. Kim KJ, Choi J, Bae JH, Kim KJ, Yoo HJ, Seo JA, et al. Time to reach target glycosylated hemoglobin is associated with long-term durable glycemic control and risk of diabetic complications in patients with newly diagnosed type 2 diabetes mellitus: a 6-year observational study. Diabetes Metab J. 2021; 45:368–78.

2. Rhee SY, Chon S, Kwon MK, Park IeB, Ahn KJ, Kim IJ, et al. Prevalence of chronic complications in Korean patients with type 2 diabetes mellitus based on the Korean national diabetes program. Diabetes Metab J. 2011; 35:504–12.

3. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020; 43(Suppl 1):S66–76.

4. Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, et al. 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea. Diabetes Metab J. 2019; 43:398–406.

5. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995; 28:103–17.

6. Chang-Chen KJ, Mullur R, Bernal-Mizrachi E. Beta-cell failure as a complication of diabetes. Rev Endocr Metab Disord. 2008; 9:329–43.

7. Lee J, Cho JH. Early glycosylated hemoglobin target achievement predicts clinical outcomes in patients with newly diagnosed type 2 diabetes mellitus. Diabetes Metab J. 2021; 45:337–8.